Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats
- PMID: 9127816
- DOI: 10.1254/jjp.73.215
Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats
Abstract
Potency and duration of muscle relaxant activity of eperisone hydrochloride were examined after percutaneous administration in the intercollicular decerebrated rat rigidity model and compared to those of eperisone after intravenous injection. A continuous movement was loaded on the hindlimb of the rat model to maintain stable rigidity. The tonus of the hindlimb was recorded by EMG from the triceps surae and was quantified by using the public domain NIH Image program. Eperisone ointment administered percutaneously showed significant muscle relaxant activity at 8.4 cm2 (4.2 mg of eperisone)/rat. The effect was dose-dependent and lasted over 60 min. Intravenously injected eperisone showed significant activity at 1.25 mg/kg, but the decrease of tone was lost within 30 min after injection. Plasma eperisone levels were monitored in the same model, and they were well correlated to the dosage. These results suggest that percutaneously administered eperisone is absorbed efficiently and shows potent and long-lasting muscle relaxant activity.
Similar articles
-
Silperisone: a centrally acting muscle relaxant.CNS Drug Rev. 2006 Fall-Winter;12(3-4):218-35. doi: 10.1111/j.1527-3458.2006.00218.x. CNS Drug Rev. 2006. PMID: 17227288 Free PMC article. Review.
-
Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.Pharmacology. 2004 Jul;71(3):150-6. doi: 10.1159/000077449. Pharmacology. 2004. PMID: 15161997
-
Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant.Arch Int Pharmacodyn Ther. 1985 May;275(1):105-22. Arch Int Pharmacodyn Ther. 1985. PMID: 3839647
-
Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.Arzneimittelforschung. 1997 Jun;47(6):706-9. Arzneimittelforschung. 1997. PMID: 9239447
-
Pharmacological properties of NK433, a new centrally acting muscle relaxant.Eur J Pharmacol. 1995 Jan 24;273(1-2):47-56. doi: 10.1016/0014-2999(94)00666-u. Eur J Pharmacol. 1995. PMID: 7737318
Cited by
-
Silperisone: a centrally acting muscle relaxant.CNS Drug Rev. 2006 Fall-Winter;12(3-4):218-35. doi: 10.1111/j.1527-3458.2006.00218.x. CNS Drug Rev. 2006. PMID: 17227288 Free PMC article. Review.
-
Oral muscle relaxant may induce immediate allergic reactions.Yonsei Med J. 2012 Jul 1;53(4):863-5. doi: 10.3349/ymj.2012.53.4.863. Yonsei Med J. 2012. PMID: 22665359 Free PMC article.
-
The key role of muscle spindles in the pathogenesis of myofascial trigger points according to ramp-and-hold stretch and drug intervention in a rat model.Front Physiol. 2024 May 14;15:1353407. doi: 10.3389/fphys.2024.1353407. eCollection 2024. Front Physiol. 2024. PMID: 38808356 Free PMC article.